Samumed Presented Data on Increases in Hair Follicles Observed in Its Phase 2 Biopsy Study for a Potential Treatment of Androgenetic Alopecia (AGA) at Annual Meeting of the American Academy of Dermatology (AAD)
Sm04554
Collapse
X
-
Samumed Presented Data on Increases in Hair Follicles Observed in Its Phase 2 Biopsy Study for a Potential Treatment of Androgenetic Alopecia (AGA) at Annual Meeting of the American Academy of Dermatology (AAD)
https://www.samumed.com/medium/image...t_63/view.aspxComment
-
-
Samumed Presented Data on Increases in Hair Follicles Observed in Its Phase 2 Biopsy Study for a Potential Treatment of Androgenetic Alopecia (AGA) at Annual Meeting of the American Academy of Dermatology (AAD)
https://www.samumed.com/medium/image...t_63/view.aspxComment
-
An experimental drug from a largely unknown biotechnology company has shown promise in regrowing bald men’s hair, according to data to be presented at the American Academy of Dermatology in Washington, D.C., today. The result is preliminary, and doctors who reviewed the presentation ahead of publication for Forbes characterized the results [...]
Keep in mind, the results are just from 90 days of use, and hair counts were performed at baseline, on day 90 and day 135. There was continued improvement even 45 days after the treatment was stopped.Comment
-
Anyone know what their next step is? If they are planning to head into phase three next or what?Comment
-
What I found interesting is this:
"
- SM04554 may be the first treatment leading to follicular neogenesis
- Both treatment groups exhibited statistically significantly higher total follicle counts compared to vehicle
"
It's notable because if I'm not mistaken, Histogen's Gail Naughton talks in one of her interviews about it being augmented a lot by something that could cause new follicles to start forming. I think Follica was suggested at the time. But this could be useful.Comment
-
Comment
-
Comment
Comment